Olukotun Adeoye Y sold 2,000 shares of ARROWHEAD PHARMACEUTICALS, INC. at $86.96 for −$174k on Aug 18, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$173,920Shares × reported price
Shares traded
2,000Common Stock
Price per share
$86.96Reported price. Read footnotes for ranges.
% of reported position traded
5.95%This security and ownership context
Holdings after
31,600Direct
Trade date
Aug 18, 2026Sell
Filed
Aug 20, 2026, 5:25 PM ET2-day reporting delay
Accession
0001242615-26-000002Code S · Transaction 13345
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 33,600 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ARWR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ARWR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −15%1w ago +2%1d ago +1.4%
Returns since7d +1.3%30d −24%90d180d1y

Footnotes in full

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.